Overview

Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients

Status:
Unknown status

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

To evaluate prevention effect of combination therapy of Everolimus and low-dose Tacrolimus in comparison with standard-dose Tacrolimus therapy with Mycophenolic acid on the New Onset Diabetes Mellitus after transplantation in the renal allograft recipients

Phase:

Phase 4

Details

Lead Sponsor:

Seoul St. Mary's Hospital

Collaborator:

Novartis

Treatments:

Everolimus
Mycophenolate mofetil
Mycophenolic Acid
Sirolimus
Tacrolimus